How should hypertension be managed to achieve a target blood pressure below 130/80 mm Hg, including lifestyle modifications and first-line pharmacologic therapy?

Blood Pressure Management to Achieve Target <130/80 mmHg

To achieve a blood pressure target below 130/80 mmHg, initiate lifestyle modifications immediately for all patients, and start pharmacologic therapy with an ACE inhibitor/ARB or calcium channel blocker (thiazide diuretic for Black patients) for high-risk patients or those with BP ≥140/90 mmHg, escalating to combination therapy as needed within 3 months. 1

Diagnostic Confirmation

• Confirm hypertension diagnosis using home BP monitoring (≥135/85 mmHg) or 24-hour ambulatory monitoring (≥130/80 mmHg) when office BP is ≥140/90 mmHg 1
• Use validated automated upper arm cuff devices with appropriate cuff size 1
• Measure BP in both arms at first visit; use the arm with higher readings for subsequent measurements 1

Lifestyle Modifications (Foundation for All Patients)

Implement these evidence-based interventions immediately, as they are partially additive and enhance medication efficacy: 2

• Weight reduction if overweight or obese 1
• Dietary sodium restriction to <6 g/day (ideally <2.3 g/day) 1
• DASH diet pattern: increased fruits, vegetables, low-fat dairy products, whole grains, fish, legumes, poultry, and lean meats 1
• Potassium supplementation through dietary sources 2
• Limit saturated fats to <10% of calories and cholesterol to <300 mg/day 1
• Physical activity: regular aerobic exercise 1
• Alcohol moderation: ≤2 drinks/day for men, ≤1 drink/day for women 1
• Complete tobacco cessation and avoidance of secondhand smoke 1

Pharmacologic Therapy Algorithm

When to Start Medications

Immediate drug therapy is indicated for: 1

• Grade 2 hypertension (BP ≥160/100 mmHg) - start immediately alongside lifestyle modifications 1
• Grade 1 hypertension (BP 140-159/90-99 mmHg) in high-risk patients:
  • Existing cardiovascular disease 1
  • Chronic kidney disease 1
  • Diabetes mellitus 1
  • Target organ damage 1
  • Age 50-80 years 1

Delayed drug therapy (after 3-6 months of lifestyle intervention): 1

• Grade 1 hypertension in low-to-moderate risk patients with persistent BP elevation 1

First-Line Drug Selection by Patient Population

For Non-Black Patients: 1

1. Start with low-dose ACE inhibitor or ARB 1
2. Add dihydropyridine calcium channel blocker (DHP-CCB) 1
3. Increase to full doses 1
4. Add thiazide or thiazide-like diuretic 1

For Black Patients: 1

1. Start with low-dose ARB + DHP-CCB OR DHP-CCB + thiazide/thiazide-like diuretic 1
2. Increase to full doses 1
3. Add diuretic or ACE inhibitor/ARB (whichever not yet used) 1

Initial Monotherapy vs. Combination Therapy

Start with 2-drug combination therapy when: 1

• Stage 2 hypertension with BP >20/10 mmHg above target 1
• Use fixed-dose combinations to improve adherence 1

Start with monotherapy when: 1

• Low-risk Grade 1 hypertension 1
• Age >80 years or frail patients 1

Resistant Hypertension (Fourth-Line Agent)

If BP remains uncontrolled on 3-drug regimen, add: 1

• Spironolactone (preferred) 1
• Alternatives if spironolactone not tolerated/contraindicated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker 1

Target Blood Pressure Goals

Standard target for most patients: 1

• BP <130/80 mmHg 1

Special populations: 1

• Diabetes mellitus: <130/80 mmHg (initiate treatment at ≥140/90 mmHg, consider at ≥130/80 mmHg after 3 months lifestyle modification) 1
• Chronic kidney disease: systolic BP 130-139 mmHg (120-129 mmHg if eGFR >30 mL/min/1.73 m² and tolerated) 1
• Elderly (≥65 years): systolic BP 130-139 mmHg 1
• Frail elderly: individualize based on tolerability 1

Monitoring and Follow-Up

• Achieve target BP within 3 months of initiating or adjusting therapy 1
• Use home BP monitoring to guide treatment adjustments 1
• Minimum BP reduction goal: 20/10 mmHg even if target not fully achieved 1
• Refer to hypertension specialist if BP remains uncontrolled despite 4-drug regimen 1

Critical Implementation Points

Common pitfalls to avoid: 1

• Beta-blockers are NOT first-line unless specific indication (e.g., heart failure, coronary disease) exists 1
• Avoid beta-blocker + thiazide diuretic combination in patients at high risk for diabetes (strong family history, obesity, metabolic syndrome, South Asian/African-Caribbean descent) due to increased diabetes incidence 1
• Use once-daily formulations effective for 24 hours to improve adherence 1
• Allow at least 4 weeks to observe full drug response before dose escalation 1

Drug dosing strategy: 1

• Titrate drugs to full manufacturer-recommended doses before adding additional agents 1
• Exception: thiazide diuretics have uncertain optimal dose; use standard recommended doses 1